neurometrix Resources | BNET
On The Insider: Amy Winehouse Has Brain Damage?

BNET Industries

NeuroMetrix (NURO) is in the Health Care Industry

Revenue
Dec 31 2007
$44.6M
Profit
Dec 31 2007
($8.3M)
Market Cap
Sep 04 2008
$15.4M

Latest News and Analysis

  • NeuroMetrix: Revenues Decline, Prospects Look Bleak

    Douglas Cress submits: NeuroMetrix NURO reported quarterly revenues of $8.5 million on Tuesday, down approximately 26% from the same period in 2007. The company generated a scant $510,000 (or 6% or revenues) from the sale of devices, including NC-stat System and the newer Advance. That could spell trouble for future...

    External links 2008-08-07

    Tags: Smallcap, Healthcare, NeuroMetrix

Additional Resources

  • page 1 of 1
  • Incorporated: 1996
  • CEO: Dr. Shai N. Gozani Ph.D.

NeuroMetrix is engaged in the design, development and selling of proprietary medical devices designed to help physicians to diagnose neuropathies and neurovascular disease. As of Dec 31 2006, Co.'s neuropathy diagnostic system, the NC-stat System, comprised of disposable single use biosensors; NC-stat device and related components; and NC-stat docking station, an optional device that enables the physician to transmit data to Co.'s onCall information system. Co. also offers DigiScopeŽ, which allows primary care physicians and endocrinologists to diagnose diabetic retinopathy and refer patients to the ophthalmologist for treatment if deemed necessary based on the results.

Key Competitors

advertisement
NeuroMetrix Company Info

Board of Directors

Dr. Shai N. Gozani Ph.D.

Chairman

Dr. David E. Goodman M.D.

Dr. Allen J. Hinkle M.D.

Mr. Charles R. LaMantia

Mr. W. Mark Lortz

Contact Information

62 Fourth Avenue

Waltham, MA

http://www.neurometrix.com

781 890-9989

NAICS Code

Surgical and Medical Instrument Manufacturing: 339112

Brought to you by IBM

advertisement